Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Because SIBO testing is uncommon in the general population, increased testing among GLP-1 users can make it appear that cases are rising, when in reality we are simply increasing testing and therefore finding more cases
Accessed October 16, 2024
Mikolajczak, P., Wiktorowicz, K., Okulicz-Kozaryn, I., Kostrzewa, A
Tirzepatide, sold as Mounjaro and Zepbound, was not separately classified in the 2022 data and was not yet approved for weight management at that time, meaning it is not reflected in these figures
US$ 29.43
US$ 29.06
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.83
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 22.71
